id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-N-0511-0003,FDA,FDA-2010-N-0511,FDA/DDM Letter to Division of Wyeth Holdings - Letter,Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2010-12-29T14:34:06Z,,0,0,0900006480bc1b46
FDA-2010-N-0511-0002,FDA,FDA-2010-N-0511,FDA/DDM Letter to Division of Wyeth Holdings - Letter,Other,,2010-12-28T00:00:00Z,2010,12,,,2010-12-29T14:18:57Z,,0,1,0900006480b77e4c
FDA-2010-N-0511-0001,FDA,FDA-2010-N-0511,Withdrawals of Approvals of New Animal Drug Applications: Aklomide; Levamisole Hydrochloride; Nitromide and Sulfanitran,Notice,NWL-Notice of Withdrawl,2010-10-26T04:00:00Z,2010,10,,,2010-10-26T18:43:35Z,2010-27010,0,0,0900006480b775a5